Skip to main content
. Author manuscript; available in PMC: 2017 Jun 1.
Published in final edited form as: Hypertension. 2016 Apr 25;67(6):1196–1204. doi: 10.1161/HYPERTENSIONAHA.115.06979

Figure 1.

Figure 1

FBF responses to BQ-123 before and after 3 months of nebivolol (panel A), metoprolol (panel B) and placebo (panel C) intervention. Values are mean±SEM. *P<0.05 refers to the difference in the FBF responses to selective ETA blockade before vs after intervention.